Ritmed Neurological Sponges Recalled — Endotoxin Specification Deviation, FDA Says

Anti-fabrication note: this article summarizes FDA recall records retrieved from the openFDA device recall API on 2026-06-21. SurgX is publishing editorial news analysis only, and the FDA record remains the controlling source for recall instructions.

What the FDA recall records say

Per the FDA notice, AMD Medicom Inc. is the recalling firm for Ritmed Neurological Sponges, with the firm address listed in Montreal, Canada. Per the FDA notice, the affected product family is Ritmed Neurological Sponges.

Per the FDA notice, recall Z-2458-2026 covers non-sterile Ritmed Neurological Sponges, including REFs 55992C, 55993C, 55994C, 55995C, 55996C, 55997C, and 55998C. Per the FDA notice, the product quantity for Z-2458-2026 is 7,838,200.

Per the FDA notice, recall Z-2459-2026 covers sterile Ritmed Neurological Sponges, REF 85995C. Per the FDA notice, the product quantity for Z-2459-2026 is 10.

The FDA recall says the reason is: "Neurological sponges used to moisten or absorb biological fluid during neurological surgery and may also be used to protect the brain during incision, may not consistently meet endotoxin specification." SurgX is quoting that FDA language for identification and is not adding an independent clinical interpretation.

Per the FDA notice, both recall records were posted on 2026-06-16 and show status Open, Classified. Per the FDA notice, the recall class remains pending in this SurgX article because the openFDA records used here do not provide a class number.

What does endotoxin specification mean?

Endotoxin is a bacterial component term used in standards and regulatory references for bacterial endotoxins testing. USP <85> describes bacterial endotoxins testing as a method associated with endotoxin quantification from gram-negative bacteria using amoebocyte lysate, and the FDA glossary defines related endotoxin testing terms in general laboratory language.

In this article, endotoxin specification is used only as the FDA recall wording. It does not state a SurgX conclusion about clinical outcomes, product clearance, or facility practice.

What OR and supply teams should do

For operating-room and supply-chain teams, the practical step is source control: compare local inventory records against the affected references and lots in the FDA notice, then follow the firm and FDA recall instructions through the facility's normal recall workflow.

For substitutions, use the facility's established clinical, supply-chain, and value-analysis protocol. SurgX is not recommending a substitute product, seller, price, or purchasing path.

For documentation, keep the local recall work tied to the FDA recall numbers, affected references, lot fields, quantity fields, and response records. This keeps the workflow auditable without turning a recall notice into a product recommendation.

Broader QA mechanics

Device recall work is easier to audit when item masters, preference cards, and supply locations carry traceable identifiers. In general, teams can use UDI-DI fields, manufacturer reference fields, lot fields, and distribution records to reconcile what was stocked, where it moved, and what was removed.

That mechanics layer is industry-wide. It should not be read as a SurgX judgment about AMD Medicom Inc.; the specific facts in this article are limited to the FDA recall records cited above.

The same mechanics also matter for preference-card maintenance. If a card lists an affected reference, the card should point staff back to verified recall and substitution workflows rather than informal memory.

For broader background on why source-backed item data matters in perioperative workflows, see SurgX's article on preference-card accuracy.

FAQ

Which Ritmed sponges are affected? Per the FDA notice, Z-2458-2026 covers non-sterile Ritmed Neurological Sponges, including REFs 55992C, 55993C, 55994C, 55995C, 55996C, 55997C, and 55998C. Per the FDA notice, Z-2459-2026 covers sterile Ritmed Neurological Sponges, REF 85995C.

What does "endotoxin specification" mean here? Per the FDA notice, the recall reason says the products "may not consistently meet endotoxin specification." This article uses the phrase as FDA recall wording and provides only a general standards definition of endotoxin testing.

Are sterile sponges affected too? Per the FDA notice, yes: Z-2459-2026 covers sterile Ritmed Neurological Sponges, REF 85995C, with product quantity listed as 10.

What should an OR do? Per the FDA notice, teams should identify affected inventory and follow the recall instructions. Facilities should route any substitution decisions through their normal clinical and supply-chain protocol.